News & Press Releases
HUBZone program has become a prime target for fraud
In a commentary piece published by Washington Technology, Baron & Budd Attorney Andrew Miller talks about how the HUBZone program has become a prime target [...]
Baron & Budd Investigates Potential Fraud Activity Among HUBZone-Certified Small Businesses
HUBZone contractors play key role in policing industry, identifying and reporting potential fraud October 8, 2018, Washington D.C. - Today, the national law firm Baron & Budd [...]
Whistleblowers Exposing the Other Side of Patient Assistance Programs
It sounds great on the surface. Pharmaceutical companies contribute hundreds of millions of dollars to organizations that work to make incredibly expensive, life-saving drugs more [...]
Baron & Budd Investigating Medicare and Medicaid Fraud in Patient Assistance Programs for Specialty Drugs
Whistleblowers play key role highlighting fraudulent charities that target public insurance programs September 24, 2018 WASHINGTON -- Today, the national law firm Baron & Budd [...]
Baron & Budd Secures $110 Million to Settle Texas Whistleblower Lawsuits Against AstraZeneca for Fraudulently Marketing Seroquel, Crestor
Suits Alleged Pharmaceutical Giant Illegally Promoted Seroquel Prescriptions for Children, Misrepresented Safety of Crestor August 07, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced [...]
Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved UsesBaron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses
Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses
Pharmaceutical Company Allegedly Violated Federal and Texas Medicaid Laws August 01, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced that Endo Pharmaceuticals Inc. (“Endo”) [...]
Baron & Budd Secures Three Additional Settlements with Virginia Defense Contractors for Alleged FCA Violations Totaling $620,000
Washington, D.C. - The national law firm of Baron & Budd today announced that the U.S. Department of Justice has reached settlements with three additional [...]
Baron & Budd Wins School Bus Whistleblower Case, Keeps San Francisco Children Safe
Employees Help End Shocking Maintenance Practices that Endangered Students SAN FRANCISCO (May 25, 2016) –The national law firm of Baron & Budd recently secured an [...]
Harassment, Shocking Disregard for Student Safety Highlight San Francisco Whistleblower Case
Whether you have children or not, this story involving a whistleblower case in San Francisco should have your blood boiling. Thankfully, it has a good [...]
